Global E-Health Forum - Hamburg 2010

25-26 October 2010, Hamburg, Germany.
The Global E-Health Forum has been conceived to create a unique opportunity to discuss potential solutions in patient-centric health management. The past three Baltic Conferences on E-Health (2007-2009) have generated considerable interest in countries far beyond the Baltic Sea Region. The reason is simple: Healthcare systems all over the world are facing very similar challenges. Demographic shifts, increased burden of chronic diseases and expensive treatments as well as the impact of globalization - to mention some of the most important ones.

Therefore, organisers of Baltic Conference on E-Health have decided to found the "Global E-Health Forum". The Global E-Health Forum will replace the Baltic Conference on E-Health and is scheduled for following dates:

Global E-Health Forum - Hamburg 2010
25-26 October 2010.

Hosts of Global E-Health Forum 2010 are the European Health Telematics Association (EHTEL), the Hamburg Chamber of Commerce and IBM in cooperation with Asklepios.

Program Outline

  • October 25, 2010
    At the Hamburg Chamber of Commerce, you may expect presentations of keynote speakers from different continents, breakout sessions (workshops and as well as discussion forums) and an accompanying exhibition of solution providers. The first day will end with a reception in the U.S. Consulate General ("the little White House at the lake Alster").
  • October 26, 2010
    The program at Asklepios clinics will offer presentations, guided tours and show cases of solution providers and a panel discussion.

If you are interested in the sponsorship opportunities (platinum sponsor, premium sponsor and sponsor/workshop) or in exhibiting at the Global E-Health Forum on October 25 in the Hamburg Chamber of Commerce, please explore:

Register now to benefit from early bird fee of Euro 299 incl. VAT. Regular fee will be Euro 399 incl. VAT. The fee includes the admission to all conference sessions, lunches, coffee breaks and the evening reception on October 25.

For further information and registration, please visit:
http://www.global-ehealth-forum.com

Most Popular Now

Time-restricted eating reshapes gene expression th…

Numerous studies have shown health benefits of time-restricted eating including increase in life span in laboratory studies, making practices like intermittent fasting a ...

Incurable liver disease may prove curable

Research led by Associate Professor Duc Dong, Ph.D., has shown for the first time that the effects of Alagille syndrome, an incurable genetic disorder that affects the li...

Scientists develop a cancer vaccine to simultaneou…

Scientists are harnessing a new way to turn cancer cells into potent, anti-cancer agents. In the latest work from the lab of Khalid Shah, MS, PhD, at Brigham and Women’s ...

AstraZeneca to acquire CinCor Pharma to strengthen…

AstraZeneca has entered into a definitive agreement to acquire CinCor Pharma, Inc. (CinCor), a US-based clinical-stage biopharmaceutical company, focused on developing no...

NextPoint Therapeutics announces $80 million Serie…

NextPoint Therapeutics, a biotechnology company developing a new world of precision immuno-oncology, announced today that it raised $80 million in Series B financing co-l...

COVID-19 vaccines, prior infection reduce transmis…

Vaccination and boosting, especially when recent, helped to limit the spread of COVID-19 in California prisons during the first Omicron wave, according to an analysis by ...

Bayer to accelerate drug discovery with Google Clo…

Bayer AG and Google Cloud announced a collaboration to drive early drug discovery that will apply Google Cloud's Tensor Processing Units (TPUs), which are custom-develope...

Study identifies potential new approach for treati…

Targeting iron metabolism in immune system cells may offer a new approach for treating systemic lupus erythematosus (SLE) - the most common form of the chronic autoimmune...

Nanotechnology may improve gene therapy for blindn…

Using nanotechnology that enabled mRNA-based COVID-19 vaccines, a new approach to gene therapy may improve how physicians treat inherited forms of blindness. A collabo...

Acquisition of Neogene Therapeutics completed

AstraZeneca has completed the acquisition of Neogene Therapeutics Inc. (Neogene), a global clinical-stage biotechnology company pioneering the discovery, development and ...

Modified CRISPR-based enzymes improve the prospect…

Many genetic diseases are caused by diverse mutations spread across an entire gene, and designing genome editing approaches for each patient’s mutation would be impractic...

Pfizer expands 'An Accord for a Healthier World' p…

Pfizer Inc. (NYSE: PFE) announced that it has significantly expanded its commitment to An Accord for a Healthier World to offer the full portfolio of medicines and vaccin...